<DOC>
	<DOCNO>NCT01183221</DOCNO>
	<brief_summary>This study examine effect oxytocin complex social cognition adult autism spectrum disorder . Participants receive one-time administration intranasal oxytocin ( placebo ) perform empathic accuracy task , novel ecologically valid measure complex social cognition , conjunction functional magnetic resonance imaging ( fMRI ) . We investigate effect oxytocin ( versus placebo ) behavioral neural correlate empathic accuracy .</brief_summary>
	<brief_title>The Effects Oxytocin Complex Social Cognition Autism Spectrum Disorders</brief_title>
	<detailed_description />
	<mesh_term>Autistic Disorder</mesh_term>
	<mesh_term>Autism Spectrum Disorder</mesh_term>
	<mesh_term>Oxytocin</mesh_term>
	<criteria>In good physical health Meet criterion ASD accord psychiatric interview use Diagnostic Statistic Manual , Fourth Edition ( DSMIV ) Must history developmental delay Must meet full criterion ASD Autism Diagnostic Interview Revised ( ADIR ) either social communication domain within two point domain ( parent available interview ) Must meet full criterion ASD Autism Diagnostic Observation Schedule Generic ( ADOSG ) social domain . Meeting ASD communication domain total domain necessary Must verbal IQ great 75 , measure Wechsler Adult Intelligence Scale Fourth Edition ( WAIS III ) . Intelligence test perform site another protocol site within past year also accept Capability perform experimental task ( i.e . read understand task instruction , cooperate procedure ) Informed consent capacity Female participant must remain birth control duration study Participants primary psychiatric diagnosis screen Participants medical history neurological disease , include , limited , epilepsy/seizure disorder ( except simple febrile seizure ) , movement disorder , tuberous sclerosis , fragile X , know genetic syndrome , know abnormal MRI/structural lesion brain Participants pregnant , give birth last six month , currently breastfeed Participants medical condition might interfere conduct study , confound interpretation study result , endanger wellbeing Participants evidence history malignancy significant hematological endocrine , cardiovascular ( include rhythm disorder ) , respiratory , renal , hepatic , gastrointestinal disease , major medical condition Participants take psychoactive medication ( ) ( e.g. , stimulant , antidepressant , antipsychotic , antiepileptic , anxiolytic , clondine ) Participants , Investigator 's opinion , might suitable study Participants involve another study whose procedure could influence performance current study Female participant stay birth control duration study Participants know contraindication MRI scan : include sever claustrophobia kind metal implant body</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>August 2010</verification_date>
</DOC>